The telemedicine market is valued at USD 396.76 billion, with a compound annual growth rate of 25.8%; demand for cost-effective and time-saving features has surged: Fortune Business Insight™

Pune, India, March 10, 2021 (Global News)-According to the report, the telemedicine market is expected to reach 396.76 billion USD by 2027, with a compound annual growth rate of 25.8%. The value of the telemedicine industry is $41.63 billion. 2019. The global telemedicine market will gain momentum from the introduction of artificial intelligence (AI)-powered booths in local shopping malls. The system can dispense more than 100 medicines from the smart medicine cabinet.
According to CMS, in the United States alone, health care spending in 2018 reached 3.6 trillion US dollars. It shows a growth of 4.6%. This indicates that out-of-pocket expenses and the rising incidence of chronic diseases have increased the cost of medical care. In addition, the increasing popularity of remote consultation and digital technology will promote the growth of the telemedicine market in the near future.
Request a sample copy of the research report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telemedicine-market-101067
Remote consulting services are cost-effective and can help healthcare professionals save time. Therefore, governments of all countries are trying to implement telemedicine services in their medical infrastructure. However, the lack of skilled healthcare professionals may hinder the demand for medications during this time.
Based on the type, due to the increasing deployment of electronic consulting services in global hospitals, the service field may remain at the forefront in the next few years. Merritt Hawkins (Merritt Hawkins) survey shows that the average waiting time for dermatologists in the United States increased from 28.8 days in 2014 to 32.2 days in 2017. The decline in the number of dermatologists is expected to promote the adoption of remote and virtual diagnostic services, thereby promoting the development of this field. Grow.
In 2019, North America generated $17.9 billion in telemedicine market share. This growth is attributed to the emergence of well-known companies such as MDLive and Teladoc in the region. At the same time, more and more remote consultations and strong support from government agencies will promote the growth of the region.
In Europe, the increasing use of digital healthcare will contribute to growth due to the implementation of favorable guidelines by government agencies. It is expected that in the next few years, with the surge in chronic disease cases, the region will continue to maintain its second position. For example, the British Skin Foundation mentioned that the United Kingdom shows about 100,000 new cases of skin cancer each year.
Quick Purchase-Telemedicine Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101067
There are many well-known companies in the global market for telemedicine, and these companies mainly focus on partnerships and acquisition strategies. They do this to expand their product portfolio and win a large consumer base. The following are the two latest industry developments:
VivaBem and Doktor.se have jointly raised approximately US$2.5 million. The fund will help them improve their existing products by integrating Doktor.se’s AI-driven technology. It will further improve users’ experience in health and healthcare services, long-term care management and telemedicine.
Get your customized research report: https://www.fortunebusinessinsights.com/enquiry/customization/telemedicine-market-101067
Glaucoma therapy market size, share and COVID-19 impact analysis, by drug category (beta blockers, prostaglandin analogs, alpha adrenergic agonists, carbonic anhydrase inhibitors, combination drugs and others), disease indications​​ (Open angle glaucoma, closed corneal glaucoma, and others), forecast by distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy) and region, 2020-2027
Cardiovascular drugs market size, share and industry analysis, according to drug type (antihypertensive, hypolipidemic, anticoagulant, antiplatelet drugs, other), disease indications (hypertension, hyperlipidemia, coronary artery disease, arrhythmia Qi, etc.), forecast by distribution channel (hospital pharmacy, retail pharmacy, online pharmacy, etc.) and region, 2019-2026
Market size of ophthalmic diseases, by disease indication (glaucoma, retinal disease, dry eye, allergy and infection), share by drug category (anti-inflammatory, anti-infective, anti-VEGF, anti-glaucoma) and industry analysis of dosage form (solid, liquid) , Semi-solid), distribution channels (hospital pharmacies, retail pharmacies, online pharmacies) and regional forecast 2019-2026
Lung cancer treatment drug market size, share by therapy category and industry analysis (targeted, therapy, immunotherapy, chemotherapy), cancer type (non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC)), distribution channels (hospitals) ) Pharmacies, retail pharmacies, online pharmacies) and regional forecasts for 2019-2026
Ultrasound equipment market size, share and COVID-19 impact analysis, by-products (compact and desktop); forecast by application (radiology, gynecology, cardiology, etc.), end users (hospitals and clinics), and region, 2020-2027
Fortune Business Insights™ provides professional enterprise analysis and accurate data to help organizations of all sizes make timely decisions. We tailor innovative solutions for our customers to help them cope with the challenges faced by their business. Our goal is to provide customers with comprehensive market intelligence and a detailed overview of the markets in which they operate.
Our report contains a unique combination of tangible insights and qualitative analysis that can help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market research and disseminate relevant data.
In “Fortune Business Insight™”, we are committed to highlighting the most profitable growth opportunities for our clients. Therefore, we have provided suggestions to make it easier for them to navigate technology and market-related changes. Our consulting services are designed to help organizations discover hidden opportunities and understand current competitive challenges.
Fortune Business Insights™ Pvt. Ltd. 308, the highest headquarters, Pune-Pune-Bangalore Highway-Baner, India, Investigation Bureau No. 36, Zip code -411045, India.
Tel: USA: +1 424 253 0390 UK: +44 2071 939123 Asia Pacific: +91 744 740 1245 Email: sales@fortunebusinessinsights.com Twitter | Blog


Post time: Mar-11-2021